[Towards a national strategy on the diagnosis of neurocognitive disorders. A shared approach among the French National College of General Practitioners and specialists of neurocognitive disorders]

Presse Med. 2018 Jan;47(1):75-83. doi: 10.1016/j.lpm.2017.10.029. Epub 2017 Dec 26.
[Article in French]

Abstract

Neurocognitive disorders leading to progressive cognitive, functional and behavioural impairment are often undiagnosed or diagnosed lately. But tailored care and therapeutics help in implementing secondary and tertiary prevention dynamics aiming at preserving quality of life and delaying, anticipating or preventing behavioural crisis and severe stages of dementia. Moreover, the diagnosis of numerous diseases induces specific care and therapeutics, as well access to research and clinical trials. For the first time, the representatives of the National College of General Practitioners, the French Federation of Memory Centres, the French Federation of Gerontology and Geriatrics, the French Federation of Neurology, the French Society of Psychogeriatrics and the national plan on neurodegenerative diseases propose a graduated and tailored diagnosis strategy involving primary care and specialists of neurocognitive disorders. This strategy has been built in the context of the national plan on neurodegenerative diseases, the European Joint Action "Act on dementia", and has been consensually agreed after a seminar animated by the National College of General Practitioners in March 2017.

MeSH terms

  • Activities of Daily Living
  • Aged, 80 and over
  • Algorithms
  • Biomarkers / cerebrospinal fluid
  • Dementia / cerebrospinal fluid
  • Dementia / diagnosis
  • Dementia / epidemiology
  • Diagnosis, Differential
  • France / epidemiology
  • General Practice
  • Health Policy*
  • Humans
  • Interdisciplinary Communication
  • Medicine*
  • Mental Disorders / diagnosis
  • Mental Status and Dementia Tests
  • Neurocognitive Disorders / diagnosis*
  • Neurocognitive Disorders / epidemiology
  • Neurocognitive Disorders / prevention & control
  • Neurocognitive Disorders / therapy
  • Neuroimaging
  • Neurologic Examination
  • Societies, Medical*

Substances

  • Biomarkers